top of page

ASCO 2026: "If you look at what happened to KRAS at this conference....we are on that path with beta-catenin." Iterion CEO Rahul Aras describes his company's approach to WNT/beta-catenin and ASCO data

  • 16 hours ago
  • 1 min read

He describes the biology of WNT/beta-catenin, an undruggable target for decades and why he believes there is now room for optimism. Iterion presented an update of its TBL1 inhibitor in hepatocellular carcinoma today in an oral presentation at ASCO.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC_IB_Stacked_logo.png

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

​

​Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

Learn more

bottom of page